Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $20 Million Underwritten Public Offering

Press Release – New York, NY – January 30, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, in the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $20.0 million, before deducting underwriting fees and other offering expenses payable by the Company.

The Sichenzia Ross Ference Carmel LLP team was led by partner Arthur Marcus and associate Jesse Blue.